Gerard M.P. Giblin

1.6k citations

54 papers · 1.2k indexed · h-index 21

Organic Chemistry top 5%
Pharmacology top 2%
Molecular Biology
Physiology top 10%
Cellular and Molecular Neuroscience top 10%

Co-authors: Alan Naylor Adrian Hall Nigel S. Simpkins Paul Goldsmith Susan H. Brown Iain P. Chessell A. R. Chowdhury Richard J. K. Taylor
Topics: Inflammatory mediators and NSAID effects (20 papers)Neuropeptides and Animal Physiology (9 papers)Asymmetric Synthesis and Catalysis (8 papers)
Cited by: Pharmacology Organic Chemistry Cellular and Molecular Neuroscience
Journals: Chemical Communications The Lancet Neurology Journal of Medicinal Chemistry
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Gerard M.P. Giblin

54 papers receiving 1.2k citations

Peers

Countries citing papers authored by Gerard M.P. Giblin

Since Specialization

Citations

This map shows the geographic impact of Gerard M.P. Giblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard M.P. Giblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard M.P. Giblin more than expected).

Fields of papers citing papers by Gerard M.P. Giblin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard M.P. Giblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard M.P. Giblin. The network helps show where Gerard M.P. Giblin may publish in the future.

Co-authorship network of co-authors of Gerard M.P. Giblin

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard M.P. Giblin. A scholar is included among the top collaborators of Gerard M.P. Giblin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard M.P. Giblin. Gerard M.P. Giblin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain 2018 ·Bioorganic & Medicinal Chemistry Letters ·Mark P. Healy,(unknown),(unknown),Andy Billinton,Iain P. Chessell,(unknown),Gerard M.P. Giblin,(unknown),(unknown),Anton D. Michel,Alan Naylor,(unknown),David J. Spalding,David A. Stevens,Martin E. Swarbrick,(unknown)	4
2	Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial 2017 ·The Lancet Neurology ·Joanna M. Zakrzewska,Joanne Palmer,Valérie Morisset,Gerard M.P. Giblin,Mark Obermann,Dominik A. Ettlin,G. Cruccu,Lars Bendtsen,Mark Estación,(unknown),Stephen G. Waxman,Gary Layton,(unknown),Simon Tate	128
3	Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia 2013 ·Trials ·Joanna M. Zakrzewska,Joanne Palmer,Dominik A. Ettlin,Mark Obermann,Gerard M.P. Giblin,Valérie Morisset,Simon Tate,(unknown)	41
4	Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonist 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Paul B. Chapman,(unknown),Gerard M.P. Giblin,Mark P. Healy,Millard H. Lambert,Lisa M. Leesnitzer,(unknown),Raymond V. Merrihew,A. Richard Rutter,Rosemary Sasse,Barry G. Shearer,Timothy M. Wilson,Robert X. Xu,David Virley	20
5	Piperidine-derived γ-secretase modulators 2009 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Richard L. Elliott,Gerard M.P. Giblin,Ishrut Hussain,(unknown),Alan Naylor,Rosemary Sasse,Beverley Smith	38
6	Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP1 receptor antagonist for the treatment of inflammatory pain 2009 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Andy Billinton,Susan H. Brown,A. R. Chowdhury,(unknown),Gerard M.P. Giblin,(unknown),Paul Goldsmith,David N. Hurst,Alan Naylor,(unknown),Tiziana Scoccitti,(unknown),Wendy J. Winchester	15
7	Discovery of GSK345931A: An EP1 receptor antagonist with efficacy in preclinical models of inflammatory pain 2008 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,Chris Budd,(unknown),Gerard M.P. Giblin,Paul Goldsmith,Thomas G. Hayhow,David N. Hurst,Alan Naylor,(unknown),Tiziana Scoccitti,(unknown),Wendy J. Winchester	23
8	Pyridine-3-carboxamides as novel CB2 agonists for analgesia 2008 ·Bioorganic & Medicinal Chemistry Letters ·William L. Mitchell,Gerard M.P. Giblin,Alan Naylor,Andrew J. Eatherton,Brian P. Slingsby,(unknown),Karamjit S. Jandu,Carl Haslam,Andrew J. Brown,Paul Goldsmith,Nick M. Clayton,Alex Wilson,Iain P. Chessell,Richard H. Green,Andrew R. Whittington,Ian D. Wall	20
9	Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping 2008 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Andy Billinton,Susan H. Brown,A. R. Chowdhury,Gerard M.P. Giblin,Paul Goldsmith,David N. Hurst,Alan Naylor,Sadhana Patel,Tiziana Scoccitti,(unknown)	23
10	Novel methylene-linked heterocyclic EP1 receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Rino A. Bit,Susan H. Brown,A. R. Chowdhury,Gerard M.P. Giblin,David N. Hurst,(unknown),Xiao Qing Lewell,Alan Naylor,Tiziana Scoccitti	10
11	Discovery of 2-[(2,4-Dichlorophenyl)amino]- N -[(tetrahydro- 2 H -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain 2007 ·Journal of Medicinal Chemistry ·Gerard M.P. Giblin,Celestine T. O’Shaughnessy,Alan Naylor,William L. Mitchell,Andrew J. Eatherton,Brian P. Slingsby,(unknown),Paul Goldsmith,Andrew J. Brown,Carl Haslam,Nick M. Clayton,Alex Wilson,Iain P. Chessell,(unknown),Richard Green	109
12	Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,A. R. Chowdhury,Gerard M.P. Giblin,(unknown),Mark P. Healy,David G. Livermore,Richard J. Wilson,Alan Naylor,(unknown),Shilina Roman,Emma Ward,(unknown)	16
13	1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,(unknown),Tanya Coleman,Gerard M.P. Giblin,Beverley Hammond,Mark P. Healy,Matthew R. Johnson,(unknown),Anton D. Michel,Alan Naylor,Riccardo Novelli,David J. Spalding,(unknown)	9
14	Structure–activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Stephen J. Atkinson,Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,(unknown),Tanya Coleman,Gerard M.P. Giblin,Robert J. Gleave,Beverley Hammond,Mark P. Healy,Matthew R. Johnson,Anton D. Michel,Alan Naylor,Riccardo Novelli,David J. Spalding,(unknown)	21
15	Discovery of novel biaryl heterocyclic EP1 receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Rino A. Bit,Susan H. Brown,(unknown),Iain P. Chessell,Tanya Coleman,Gerard M.P. Giblin,David N. Hurst,(unknown),Xiao Qing Lewell,Anton D. Michel,(unknown),Alan Naylor,Riccardo Novelli,(unknown),David J. Spalding,(unknown),Richard J. Wilson	16
16	GW627368X ((N‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2H‐benzo[f]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP₄ receptor antagonist 2006 ·British Journal of Pharmacology ·Richard J. Wilson,Gerard M.P. Giblin,(unknown),(unknown),(unknown),(unknown),Jason Brown,Alan Wise,(unknown),(unknown),(unknown),(unknown),Terry Kenakin,Cynthia L. Burns-Kurtis,V. Morrison,David W. Gray,Heather Giles	71
17	Identification of novel glycine sulfonamide antagonists for the EP1 receptor 2006 ·Bioorganic & Medicinal Chemistry Letters ·Stephen C. McKeown,Adrian Hall,(unknown),Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,Gerard M.P. Giblin,Mark P. Healy,Matthew R. Johnson,Olivier Lorthioir,Anton D. Michel,Alan Naylor,Xiao Qing Lewell,Shilina Roman,Steve P. Watson,Wendy J. Winchester,Richard J. Wilson	13
18	1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure–activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,(unknown),Tanya Coleman,Gerard M.P. Giblin,Beverley Hammond,Mark P. Healy,Matthew R. Johnson,(unknown),Anton D. Michel,Alan Naylor,Riccardo Novelli,David J. Spalding,(unknown),(unknown)	12
19	Unexpected Z-stereoselectivity in the Ramberg–Bäcklund reaction of diarylsulfones leading to cis-stilbenes: the effect of aryl substituents and application in the synthesis of the integrastatin nucleus 2005 ·Organic & Biomolecular Chemistry ·Jonathan S. Foot,Gerard M.P. Giblin,Adrian C. Whitwood,Richard J. K. Taylor	15
20	Discovery of an Orally Bioavailable NK1 Receptor Antagonist, (2S,3S)-(2-Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with Potent Antiemetic Activity 1995 ·Journal of Medicinal Chemistry ·P. Ward,Duncan Armour,(unknown),Brian Evans,Gerard M.P. Giblin,Nicola M. Heron,(unknown),Kai Liang,David Middlemiss	41

About Gerard M.P. Giblin

Gerard M.P. Giblin is a scholar working on Pharmacology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (20 papers), Neuropeptides and Animal Physiology (9 papers) and Asymmetric Synthesis and Catalysis (8 papers). The work is most often cited by research in Pharmacology (411 citations), Organic Chemistry (527 citations) and Cellular and Molecular Neuroscience (239 citations). Gerard M.P. Giblin has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Alan Naylor, Adrian Hall, Nigel S. Simpkins, Paul Goldsmith, Susan H. Brown, Iain P. Chessell, A. R. Chowdhury, Richard J. K. Taylor, Joanne Palmer and Valérie Morisset. Their work appears in journals such as Chemical Communications, The Lancet Neurology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact